Ghassan M. Matar
American University of Beirut
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ghassan M. Matar.
The New England Journal of Medicine | 1995
David H. Spach; Andrew S. Kanter; Molly J. Dougherty; Ann Larson; Marie B. Coyle; Don J. Brenner; Bala Swaminathan; Ghassan M. Matar; D F Welch; Richard K. Root; Walter E. Stamm
BACKGROUND Bartonella (Rochalimaea) quintana is a fastidious gram-negative bacterium known to cause trench fever, cutaneous bacillary angiomatosis, and endocarditis. Between January and June 1993 in Seattle, we isolated B. quintana from 34 blood cultures obtained from 10 patients not known to be infected with the human immunodeficiency virus (HIV). METHODS After identifying the isolates as B. quintana by direct immunofluorescence and DNA-hybridization studies, we determined strain hybridization with studies of restriction-fragment-length polymorphisms (RFLPs) of the intergenic spacer (noncoding) region of ribosomal DNA amplified by the polymerase chain reaction (PCR). To characterize the epidemiologic and clinical features of bartonella infections in these patients, we performed a retrospective case-control study using as controls 20 patients with blood cultures obtained at approximately the same time as those obtained from the index patients. RESULTS B. quintana isolates from the 10 patients were indistinguishable by PCR-RFLP typing. All 10 patients had chronic alcoholism, and 8 were homeless (P = 0.001 for both comparisons with controls). The six patients who underwent HIV testing were seronegative. At the time of their initial presentation, seven patients had temperatures of at least 38.5 degrees C. Six patients had three or more blood cultures that were positive for B. quintana, and in four of these patients B. quintana was isolated from blood cultures obtained 10 or more days apart. Subacute endocarditis developed in two patients and required surgical removal of the infected aortic valve in one of them. Nine patients recovered; one died of sepsis from Streptococcus pneumoniae infection. CONCLUSIONS B. quintana is a cause of fever, bacteremia, and endocarditis in HIV-seronegative, homeless, inner-city patients with chronic alcoholism.
Antimicrobial Agents and Chemotherapy | 2010
Amélie Carrër; Laurent Poirel; Mesut Yilmaz; Özay Arikan Akan; Cilli Feriha; Gaelle Cuzon; Ghassan M. Matar; Patrick Honderlick; Patrice Nordmann
ABSTRACT Eighteen carbapenem-resistant, OXA-48-positive enterobacterial isolates recovered from Turkey, Lebanon, Egypt, France, and Belgium were analyzed. In most isolates, similar 70-kb plasmids carrying the carbapenemase gene blaOXA-48 were identified. That gene was located within either transposon Tn1999 or transposon Tn1999.2, which was always inserted within the same gene. This work highlights the current plasmid-mediated dissemination of the OXA-48 carbapenemase worldwide.
International Journal of Systematic and Evolutionary Microbiology | 1996
Dorsey L. Kordick; B. Swaminathan; Craig E. Greene; Kenneth H. Wilson; Anne M. Whitney; Steve O'connor; D G Hollis; Ghassan M. Matar; Arnold G. Steigerwalt; Georgia B. Malcolm; Peggy S. Hayes; Ted L. Hadfield; Edward B. Breitschwerdt; Don J. Brenner
Two bacterial strains, one isolated from the blood of a dog with valvular endocarditis and one isolated from the blood of a healthy dog, were similar to Bartonella species, as determined by a number of phenotypic criteria, including growth characteristics, biochemical reactions, and cell wall fatty acid composition. The results of 16S rRNA gene sequence similarity studies confirmed that these strains are closely related and belong in the genus Bartonella and that Bartonella vinsonii is their closest relative (the 16S rRNA of isolate 93-C01T [T = type strain] was 99.37% identical to the 16S rRNA of the type strain of B. vinsonii, the 16S rRNA of isolate G7464 was 99.61% identical to the 16S rRNA of the type strain, and the 16S rRNAs of the dog isolates were 99.77% identical to each other). The 16S rRNAs of both strains contained a 12-base insertion that was not present in the 16S rRNA of the type strain of any Bartonella species. DNA relatedness tests revealed that these strains were related at the species level to the type strain of B. vinsonii. They were, however, significantly more closely related to each other than to B. vinsonii. On the basis of their unique 16S rRNA sequence insertion, their preferentially high level of relatedness, and their similar origins (dogs), we believe that strains 93-C01(T) and G7464 should be placed in a separate subspecies of B. vinsonii, for which we propose the name B. vinsonii subsp. berkhoffii subsp. nov. The type strain of B. vinsonii subsp. berkhoffii is strain 93-C01 (= ATCC 51672). The description of B. vinsonii is emended to accommodate the new subspecies, and B. vinsonii subsp. vinsonii is described.
Journal of Clinical Microbiology | 2008
Mireille M. Kattar; Rola F. Jaafar; George F. Araj; Philippe Le Flèche; Ghassan M. Matar; Roland Abi Rached; Simon Khalife; Gilles Vergnaud
ABSTRACT Brucellosis remains an important anthropozoonosis worldwide. Brucella species are genetically homogeneous, and thus, the typing of Brucella species for epidemiological purposes by conventional molecular typing methods has remained elusive. Although many methods could segregate isolates into the phylogenetically recognized taxa, limited within-species genetic diversity has been identified. Recently, multilocus variable-number tandem-repeat analysis (MLVA) was found to have a high degree of resolution when it was applied to collections of Brucella isolates from geographically widespread locations, and an assay comprising 16 such loci (MLVA-16) was proposed. This scheme includes eight minisatellite loci (panel 1) and eight microsatellites (panel 2, which is subdivided into panels 2A and 2B). The utility of MLVA-16 for the subtyping of human Brucella isolates from geographically restricted regions needs to be further evaluated, and genotyping databases with worldwide coverage must be progressively established. In the present study, MLVA-16 was applied to the typing of 42 human Brucella isolates obtained from 41 patients recovered from 2002 to 2006 at a tertiary-care center in Lebanon. All isolates were identified as Brucella melitensis by MLVA-16 and were found to be closely related to B. melitensis isolates from neighboring countries in the Middle East when their genotypes were queried against those in the web-based Brucella2007 MLVA database (http://mlva.u-psud.fr/ ). Panel 2B, which comprised the most variable loci, displayed a very high discriminatory power, while panels 1 and 2A showed limited diversity. The most frequent genotype comprised seven isolates obtained over 7 weeks in 2002, demonstrating an outbreak from a common source. Two isolates obtained from one patient 5 months apart comprised another genotype, indicating relapsing disease. These findings confirm that MLVA-16 has a good discriminatory power for species determination, typing of B. melitensis isolates, and inferring their geographical origin. Abbreviated panel 2B could be used as a short-term epidemiological tool in a small region of endemicity.
International Journal of Antimicrobial Agents | 2013
Maysa Baroud; I. Dandache; George F. Araj; Rima Wakim; Souha S. Kanj; Zeina A. Kanafani; Marie-Therese Khairallah; Ahmad Sabra; Marwa Shehab; Ghassan Dbaibo; Ghassan M. Matar
A recent increase in carbapenem resistance among extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae and Escherichia coli isolates at a major tertiary care centre in Lebanon prompted the initiation of this study. Consecutive ESBL-producing isolates were tested for resistance to carbapenems, with initial screening by disk diffusion and Etest using ertapenem. The modified Hodge test was also performed. PCR of β-lactamase-encoding genes, including bla(NDM-1), bla(KPC), bla(OXA-48), bla(CTX-M), bla(TEM), bla(SHV), bla(CMY-2) and bla(OXA-1), as well as outer membrane porin genes (ompC and ompF) was performed. Sequencing, efflux pump inhibitor tests and random amplified polymorphic DNA (RAPD) analysis were performed. In total, 14 (2.45%) of 572 K. pneumoniae and 24 (1.07%) of 2243 E. coli were ertapenem-non-susceptible [minimum inhibitory concentration (MIC) ≥0.25 μg/mL]. Resistance to other carbapenems was variable. PCR and sequencing analysis revealed that isolates harboured different β-lactamase genes, including bla(OXA-1), bla(CTX-M-15), bla(TEM-1), bla(CMY-2), bla(OXA-48) and bla(NDM-1). In addition, K. pneumoniae lacked the outer membrane porin-encoding genes, whilst E. coli harboured them with detected mutations. CTX-M-15 was carried on a 90 kb plasmid, whilst OXA-48 was carried on a 70 kb plasmid. Efflux pump inhibition significantly decreased MICs in E. coli. RAPD analysis demonstrated genomic variability. In conclusion, carbapenem resistance in ESBL-producing K. pneumoniae and E. coli is due to the combined effect of β-lactamases with porin impermeability and/or efflux pump activity observed in these organisms, and in a number of isolates is due to the production of the carbapenemase-encoding genes bla(OXA-48) and the newly emerging bla(NDM-1).
Annals of Tropical Medicine and Parasitology | 2010
A. Benouda; O. Touzani; Marie-Therese Khairallah; George F. Araj; Ghassan M. Matar
Abstract The frequency of carbapenem resistance due to class-D β-lactamases (i.e. oxacillinases) among the worlds Enterobacteriaceae is increasing. Recently, in Morocco, two isolates of carbapenem-resistant Klebsiella pneumoniae were recovered from the same patient, one harbouring plasmid-encoded bla- OXA-48 and the other the bla- OXA-1 gene. This represents the first evidence of bla OXA-48-mediated carbapenem-resistance in Enterobacteriaceae in Morocco.
Clinical Microbiology and Infection | 2008
Ghassan M. Matar; Gaelle Cuzon; George F. Araj; Thierry Naas; John E. Corkill; Mireille M. Kattar; Patrice Nordmann
Aktas Z, 2008, CHEMOTHERAPY, V54, P101, DOI 10.1159-000118661; Clinical and Laboratory Standards Institute, 2005, M100S15 CLSI S; CUZON G, 2007, ANTIMICROB AGENTS CH, V52, P796, DOI 10.1128-AAC.01180-07; Deshpande LM, 2006, MICROB DRUG RESIST, V12, P223, DOI 10.1089-mdr.2006.12.223; Gulmez D, 2008, INT J ANTIMICROB AG, V31, P523, DOI 10.1016-j.ijantimicag.2008.01.017; Kanj SS, 2008, CLIN MICROBIOL INFEC, V14, P501, DOI 10.1111-j.1469-0691.2008.01964.x; Leavitt A, 2007, ANTIMICROB AGENTS CH, V51, P3026, DOI 10.1128-AAC.00299-07; Naas T, 2003, ANTIMICROB AGENTS CH, V47, P19, DOI 10.1128-AAC.47.1.19-26.2003; Navon-Venezia S, 2006, ANTIMICROB AGENTS CH, V50, P3098, DOI 10.1128-AAC.00438-06; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128-AAC.48.1.15-22.2004; Poirel L, 2007, FUTURE MICROBIOL, V2, P501, DOI 10.2217-17460913.2.5.501; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128-CMR.00001-07
Annals of Tropical Medicine and Parasitology | 2010
Ghassan M. Matar; I. Dandache; A. Carrër; Marie-Therese Khairallah; P. Nordmann; Ahmad Sabra; George F. Araj
Aktas Z, 2008, CHEMOTHERAPY, V54, P101, DOI 10.1159-000118661; BROWN DFJ, 1991, J ANTIMICROB CHEMOTH, V27, P185, DOI 10.1093-jac-27.2.185; Carrer A, 2008, ANTIMICROB AGENTS CH, V52, P2950, DOI 10.1128-AAC.01672-07; CARRER A, 2010, ANTIMICROBIAL AGENTS, V54, P1312; Cuzon G, 2008, ANTIMICROB AGENTS CH, V52, P3463, DOI 10.1128-AAC.00543-08; Gulmez D, 2008, INT J ANTIMICROB AG, V31, P523, DOI 10.1016-j.ijantimicag.2008.01.017; Kanj SS, 2008, CLIN MICROBIOL INFEC, V14, P501, DOI 10.1111-j.1469-0691.2008.01964.x; Leavitt A, 2007, ANTIMICROB AGENTS CH, V51, P3026, DOI 10.1128-AAC.00299-07; Matar GM, 2008, CLIN MICROBIOL INFEC, V14, P887, DOI 10.1111-j.1469-0691.2008.02059.x; Naas T, 2003, ANTIMICROB AGENTS CH, V47, P19, DOI 10.1128-AAC.47.1.19-26.2003; Poirel L, 2007, FUTURE MICROBIOL, V2, P501, DOI 10.2217-17460913.2.5.501; 2005, M100S15 CLIN LAB S S
Journal of Infection and Public Health | 2012
Rima I. El-Herte; Souha S. Kanj; Ghassan M. Matar; George F. Araj
Bacterial resistance to antimicrobial agents is increasing. Complex resistant mechanisms have resulted in a wide spectrum of species and strains with multidrug-resistant patterns. In addition to the production of extended-spectrum-β-lactamases (ESBLs), Gram-negative rods have acquired the capacity to hydrolyze carbapenem antibiotics by means of carbapenemases. The enzyme that has gained the most publicity recently is the New Delhi metallo-β-lactamase (NDM-1). This enzyme and others are now spreading from their homeland on the Indian subcontinent to other continents, primarily via medical tourists. This spread contributes to be a global threat in an era when no potent antibiotics are expected to be developed. Patients coming from countries where antimicrobial use is not restricted, such as Iraq, may harbor similar organisms. Reports from the Middle East and Arabian countries describing the occurrence of carbapenem-resistant Enterobacteriaceae are rare. In this communication, an update on the epidemiology, prevalence and mechanisms of carbapenem-resistant Enterobacteriaceae in Lebanon and the surrounding region will be addressed in addition to the detection methods and required infection control practices.
Annals of Tropical Medicine and Parasitology | 2007
Ghassan M. Matar; R. Jaafar; Ahmad Sabra; C. A. Hart; J. E. Corkill; Ghassan Dbaibo; George F. Araj
Abstract The emergence in Shigella species of extended-spectrum beta-lactamases (ESBL) that impart resistance to third-generation cephalosporins is a growing concern world-wide. So far, however, ESBL-producing Shigella have only been reported seven times, albeit from seven different countries. In Lebanon, three ESBL-producing clinical isolates of S. sonnei were recovered from 30 cases of shigellosis diagnosed between July 2004 and October 2005. All three were found to be resistant to amoxycillin, cefotaxime, ceftazidime, aztreonam, trimethoprim/sulphamethoxazole, gentamicin, and kanamycin. Each harboured the bla-CTX-M gene, and the results of sequence analysis indicated this to be of the bla-CTX-M-15 type and encoded on a 70-kb plasmid, flanked by an insertion element (ISEcp1). The bla-TEM-1 gene was also detected on the chromosomes of two of the ESBL-producing isolates. Class-2 integrons containing dhfr1, aadA1 and sat1 genes were detected on the chromosomes of all three isolates but not on the plasmids. Fluoroquinolone-modifying factors [QnrA, QnrB, QnrS or AAC(6′)-Ib-cr] were not detected. The results of RAPD analysis, combined with data on antimicrobial susceptibility, indicated that each isolate was unique. In conclusion, the emergence of ESBL-producing isolates of S. sonnei has been demonstrated for the first time in Lebanon. The resistance of these isolates to third-generation cephalosporins was mediated by the CTX-M-15 enzyme, which was plasmid-encoded.